Aurélien Pouille
About Aurélien Pouille
Aurélien Pouille is the Responsable Régional Médico-Scientifique in Immuno-Oncologie at Bristol-Myers Squibb, with extensive experience in medical science liaison roles, particularly in oncology.
Title and Current Role
Aurélien Pouille is currently serving as Responsable Régional Médico-Scientifique in Immuno-Oncologie at Bristol-Myers Squibb. In this role, Pouille is responsible for regional medical and scientific affairs related to immuno-oncology.
Professional Experience
Aurélien Pouille has extensive experience in various roles within the pharmaceutical industry. He has previously worked at Roche as a Medical Science Liaison in the DOM-TOM region focusing on oncological and gynecological cancers. Pouille also held a pricing project leader position at Bayer in Lille, Haunts-de-France, France. At Roche, he gained experience in medico-economic affairs and worked on the Kadcyla oncology franchise as an associate international payer strategy leader in Basel, Switzerland. His role in market access and public affairs at Sanofi Genzyme adds to his comprehensive background in the pharma sector.
Educational Background
Aurélien Pouille achieved a Master's degree from Université Paris Dauphine - PSL, from 2014 to 2015. He also holds a Master of Science from Paris-Sud University (Paris XI), where he studied from 2012 to 2013. Additionally, Pouille earned a Doctorate, Doctor of Pharmacy, from Paris-Sud University (Paris XI) from 2008 to 2014.
Experience in Medical Science Liaison Roles
Aurélien Pouille has extensive experience in medical science liaison (MSL) roles, particularly in the field of oncology. His tenure at Roche included working as an MSL in the DOM-TOM region, focusing on oncological and gynecological cancers. He has also contributed significantly to the field of medical science through various positions at other reputable pharmaceutical companies, further showcasing his expertise and commitment to the industry.
Roles in Market Access and Pricing
Aurélien Pouille has a background in market access and public affairs from his role at Sanofi Genzyme in 2014. Moreover, his stint as a pricing project leader at Bayer in Lille, Hauts-de-France, France, further highlights his competence in the economic aspects of the pharmaceutical industry. His varied positions have equipped him with a thorough understanding of pricing and access strategies essential for pharmaceutical products.